A Case of Lactic Acidosis Caused by Linezolid Treatment of Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia |
Kim, Yu-Seok
(Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine)
Kim, Ji-Beom (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) Lee, Yu-Mi (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) Kim, Sung-Han (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) Choi, Sang-Ho (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) Woo, Jun-Hee (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) Kim, Yang-Soo (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) |
1 | Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-1982. DOI ScienceOn |
2 | Jang HC, Kim SH, Kim KH, et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 2009;49:395-401. DOI ScienceOn |
3 | Beekmann SE, Gilbert DN, Polgreen PM; IDSA Emerging Infections Network. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis 2008;62:407-410. DOI ScienceOn |
4 | Rachoin JS, Weisberg LS, McFadden CB. Treatment of lactic acidosis: appropriate confusion. J Hosp Med 2010;5:E1-E7. DOI |
5 | McKee EE, Ferguson M, Bentley AT, Marks TA. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother 2006;50:2042-2049. DOI ScienceOn |
6 | De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006;42:1111-1117. DOI ScienceOn |
7 | Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med 2003;348:86-87. DOI ScienceOn |
8 | Fung HB, Kirschenbaum HL, Ojofeitimi BO. Linezolid: an oxazolidinone antimicrobial agent. Clin Ther 2001;23:356-391. DOI ScienceOn |
9 | Garrabou G, Soriano A, Lopez S, et al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother 2007;51:962-967. DOI ScienceOn |
10 | Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52:285-292. DOI ScienceOn |
11 | Scotton P, Fuser R, Torresan S, et al. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis. Infection 2008;36:387-388. DOI ScienceOn |
12 | Wiener M, Guo Y, Patel G, Fries BC. Lactic acidosis after treatment with linezolid. Infection 2007;35:278-281. DOI ScienceOn |
13 | Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med 2005;353:2305-2306. DOI ScienceOn |
14 | Chung SK, Jeon JS, Noh HJ, et al. A case of lactic acidosis associated with prolonged linezolid therapy. Korean J Nephrol 2009;28:41-43. |